The transformation of benign lesions into CM is due to the loss of CDKN2A, PTEN and TP53 functions via a mutation-dependent mechanism, leading to enhanced tumor progression, invasion and metastasis [31,32]. This evidence concerns the gene PTEN and neoplasm.